You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 13, 2024

CLINICAL TRIALS PROFILE FOR BMS-986278


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for BMS-986278

Trial ID Title Status Sponsor Phase Summary
NCT03429933 ↗ A Study of Experimental Medication BMS-986278 Given to Healthy Participants Completed Bristol-Myers Squibb Phase 1 The purpose of this study is to investigate experimental medication BMS-986278 given to healthy participants.
NCT03712540 ↗ An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants Completed Bristol-Myers Squibb Phase 1 The purpose of this study is to investigate the effects of experimental medication BMS-986278 given with the antibiotic Rifampin in healthy participants.
NCT03981094 ↗ A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants Completed Bristol-Myers Squibb Phase 1 The main objectives of this study are to characterize the PK of BMS-986278 after administration of a single dose of BMS-986278 alone or in combination with pirfenidone, as well as to characterize the PK of pirfenidone after administration of a single dose of pirfenidone alone or in combination with BMS-986278
NCT04308681 ↗ A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis Recruiting Bristol-Myers Squibb Phase 2 The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these participants.
NCT04468815 ↗ A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole) Not yet recruiting Bristol-Myers Squibb Phase 1 The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants.
NCT04567667 ↗ Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants Not yet recruiting Bristol-Myers Squibb Phase 1 The purpose of this study is to assess the way the body absorbs, distributes, breaks down and eliminates radioactive BMS-986278 as well as the safety and tolerability of BMS-986278 in healthy male participants.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for BMS-986278

Condition Name

Condition Name for
Intervention Trials
Healthy Participants 4
Healthy Volunteers 2
Idiopathic Pulmonary Fibrosis (IPF) 1
Pulmonary Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Pulmonary Fibrosis 2
Fibrosis 1
Idiopathic Pulmonary Fibrosis 1
Idiopathic Interstitial Pneumonias 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BMS-986278

Trials by Country

Trials by Country for
Location Trials
United States 25
Japan 9
Argentina 6
Australia 5
Mexico 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Utah 3
Kansas 2
Wisconsin 2
Massachusetts 1
Arizona 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BMS-986278

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 2 1
Phase 1 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Not yet recruiting 4
Completed 3
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BMS-986278

Sponsor Name

Sponsor Name for
Sponsor Trials
Bristol-Myers Squibb 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.